NeurogeneNGNE
那斯達克 · USD
28.01
-0.80
(-2.78%)
收盤 06/11 03:59 (UTC+8)
06/11 03:59 (UTC+8)
NeurogeneNGNE
28.01
-0.80
(-2.78%)
財務數據
損益表
- -
- -
- 0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | 925 | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | 925 | - | - |
營業費用 | 33,349 | 27,529 | 23,799 | 26,081 | - | - | 22,180 | - | 18,779 | 14,733 |
研發費用 | 25,150 | 20,639 | 17,241 | 19,371 | 17,760 | 15,347 | 16,285 | 15,744 | 13,541 | 12,184 |
推銷及管理費用 | 8,199 | 6,890 | 6,558 | 6,710 | 8,159 | 6,165 | 5,895 | 5,315 | 5,238 | 2,549 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -33,349 | -27,529 | -23,799 | -26,081 | -25,919 | -21,512 | -22,180 | -20,134 | -18,779 | -14,733 |
其他收入及費用 | 2,415 | 2,795 | 2,847 | 4,066 | 3,274 | 2,000 | 1,966 | 1,646 | 1,861 | 17,119 |
利息費用 | - | 1 | 1 | 1 | 2 | 2 | 3 | 4 | 3 | 3 |
稅前純益 | -30,934 | -24,735 | -20,953 | -22,016 | -22,647 | -19,514 | -20,217 | -18,492 | -16,921 | 2,383 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -30,934 | -24,735 | -20,953 | -22,016 | -22,647 | -19,514 | -20,217 | -18,492 | -16,921 | 2,383 |
基本每股稅後盈餘(元) | -1.39 | -1.12 | -0.99 | -1.05 | -1.08 | -1.00 | -1.19 | -1.09 | -1.00 | - |
稀釋每股稅後盈餘(元) | -1.39 | -1.13 | -0.99 | -1.05 | -1.08 | -0.99 | -1.20 | -1.09 | -1.00 | 87.66 |
基本平均股數(千股) | 22305.00 | 22086.00 | 21168.00 | 21055.00 | 20996.00 | 19471.00 | 16953.00 | 16941.00 | 16903.00 | - |
稀釋平均股數(千股) | 22305.00 | 22086.00 | 21168.00 | 21055.00 | 20996.00 | 19471.00 | 16953.00 | 16941.00 | 16903.00 | - |
還原基本每股稅後盈餘(元) | -1.39 | -1.12 | -0.99 | -1.05 | -1.08 | -1.00 | -1.19 | -1.09 | -1.00 | - |
還原稀釋每股稅後盈餘(元) | -1.39 | -1.13 | -0.99 | -1.05 | -1.08 | -0.99 | -1.20 | -1.09 | -1.00 | 87.66 |
還原基本平均股數(千股) | 22,305 | 22,086 | 21,168 | 21,055 | 20,996 | 19,471 | 16,953 | 16,941 | 16,903 | - |
還原稀釋平均股數(千股) | 22,305 | 22,086 | 21,168 | 21,055 | 20,996 | 19,471 | 16,953 | 16,941 | 16,903 | - |
EBITDA(千元) | -30,454 | -24,447 | -20,992 | -22,721 | -23,630 | -19,673 | -20,095 | -17,997 | -16,539 | 3,109 |